Filtered By:
Procedure: Hysterectomy

This page shows you your search results in order of date. This is page number 16.

Order by Relevance | Date

Total 4228 results found since Jan 2013.

Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy
Conditions:   Post Operative Pain;   Gynecologic Cancer Interventions:   Drug: Liposomal bupivacaine;   Drug: Bupivacain Sponsor:   Tufts Medical Center Not yet recruiting
Source: ClinicalTrials.gov - March 10, 2023 Category: Research Source Type: clinical trials

Assessing Health Care Utilization and Feasibility of Transurethral Catheter Self-Discontinuation
CONCLUSION: Catheter self-discontinuation is a feasible alternative to in-office voiding trials on postoperative day 1 after advanced benign gynecologic and urogynecologic surgery, with low rates of subsequent retention and no adverse events seen in our pilot study.PMID:36897148 | DOI:10.1097/AOG.0000000000005105
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Abigail Davenport Yi Li Emily Melvin Arthur Arcaz Lucie Lefbom Cheryl B Iglesia Alexis A Dieter Source Type: research

Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review
CONCLUSION: On average, patients use the equivalent of 15 or fewer 5-mg oxycodone tablets (or equivalent) in the 2 weeks after discharge after major gynecologic surgery for benign indications. Persistent opioid use occurred in 4.4% of patients who underwent gynecologic surgery for benign indications. Our findings could help surgeons minimize overprescribing and reduce medication diversion or misuse.SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020146120.PMID:36897135 | DOI:10.1097/AOG.0000000000005104
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Kristen A Matteson Megan O Schimpf Peter C Jeppson Jennifer C Thompson Rajiv B Gala Sunil Balgobin Ankita Gupta Deslyn Hobson Cedric Olivera Ruchira Singh Amanda B White Ethan M Balk Kate V Meriwether Society of Gynecologic Surgeons Systematic Review Grou Source Type: research

Assessing Health Care Utilization and Feasibility of Transurethral Catheter Self-Discontinuation
CONCLUSION: Catheter self-discontinuation is a feasible alternative to in-office voiding trials on postoperative day 1 after advanced benign gynecologic and urogynecologic surgery, with low rates of subsequent retention and no adverse events seen in our pilot study.PMID:36897148 | DOI:10.1097/AOG.0000000000005105
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Abigail Davenport Yi Li Emily Melvin Arthur Arcaz Lucie Lefbom Cheryl B Iglesia Alexis A Dieter Source Type: research

Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review
CONCLUSION: On average, patients use the equivalent of 15 or fewer 5-mg oxycodone tablets (or equivalent) in the 2 weeks after discharge after major gynecologic surgery for benign indications. Persistent opioid use occurred in 4.4% of patients who underwent gynecologic surgery for benign indications. Our findings could help surgeons minimize overprescribing and reduce medication diversion or misuse.SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020146120.PMID:36897135 | DOI:10.1097/AOG.0000000000005104
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Kristen A Matteson Megan O Schimpf Peter C Jeppson Jennifer C Thompson Rajiv B Gala Sunil Balgobin Ankita Gupta Deslyn Hobson Cedric Olivera Ruchira Singh Amanda B White Ethan M Balk Kate V Meriwether Society of Gynecologic Surgeons Systematic Review Grou Source Type: research

Assessing Health Care Utilization and Feasibility of Transurethral Catheter Self-Discontinuation
CONCLUSION: Catheter self-discontinuation is a feasible alternative to in-office voiding trials on postoperative day 1 after advanced benign gynecologic and urogynecologic surgery, with low rates of subsequent retention and no adverse events seen in our pilot study.PMID:36897148 | DOI:10.1097/AOG.0000000000005105
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Abigail Davenport Yi Li Emily Melvin Arthur Arcaz Lucie Lefbom Cheryl B Iglesia Alexis A Dieter Source Type: research

Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review
CONCLUSION: On average, patients use the equivalent of 15 or fewer 5-mg oxycodone tablets (or equivalent) in the 2 weeks after discharge after major gynecologic surgery for benign indications. Persistent opioid use occurred in 4.4% of patients who underwent gynecologic surgery for benign indications. Our findings could help surgeons minimize overprescribing and reduce medication diversion or misuse.SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020146120.PMID:36897135 | DOI:10.1097/AOG.0000000000005104
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Kristen A Matteson Megan O Schimpf Peter C Jeppson Jennifer C Thompson Rajiv B Gala Sunil Balgobin Ankita Gupta Deslyn Hobson Cedric Olivera Ruchira Singh Amanda B White Ethan M Balk Kate V Meriwether Society of Gynecologic Surgeons Systematic Review Grou Source Type: research

Assessing Health Care Utilization and Feasibility of Transurethral Catheter Self-Discontinuation
CONCLUSION: Catheter self-discontinuation is a feasible alternative to in-office voiding trials on postoperative day 1 after advanced benign gynecologic and urogynecologic surgery, with low rates of subsequent retention and no adverse events seen in our pilot study.PMID:36897148 | DOI:10.1097/AOG.0000000000005105
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Abigail Davenport Yi Li Emily Melvin Arthur Arcaz Lucie Lefbom Cheryl B Iglesia Alexis A Dieter Source Type: research

Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review
CONCLUSION: On average, patients use the equivalent of 15 or fewer 5-mg oxycodone tablets (or equivalent) in the 2 weeks after discharge after major gynecologic surgery for benign indications. Persistent opioid use occurred in 4.4% of patients who underwent gynecologic surgery for benign indications. Our findings could help surgeons minimize overprescribing and reduce medication diversion or misuse.SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020146120.PMID:36897135 | DOI:10.1097/AOG.0000000000005104
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Kristen A Matteson Megan O Schimpf Peter C Jeppson Jennifer C Thompson Rajiv B Gala Sunil Balgobin Ankita Gupta Deslyn Hobson Cedric Olivera Ruchira Singh Amanda B White Ethan M Balk Kate V Meriwether Society of Gynecologic Surgeons Systematic Review Grou Source Type: research

Assessing Health Care Utilization and Feasibility of Transurethral Catheter Self-Discontinuation
CONCLUSION: Catheter self-discontinuation is a feasible alternative to in-office voiding trials on postoperative day 1 after advanced benign gynecologic and urogynecologic surgery, with low rates of subsequent retention and no adverse events seen in our pilot study.PMID:36897148 | DOI:10.1097/AOG.0000000000005105
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Abigail Davenport Yi Li Emily Melvin Arthur Arcaz Lucie Lefbom Cheryl B Iglesia Alexis A Dieter Source Type: research

Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review
CONCLUSION: On average, patients use the equivalent of 15 or fewer 5-mg oxycodone tablets (or equivalent) in the 2 weeks after discharge after major gynecologic surgery for benign indications. Persistent opioid use occurred in 4.4% of patients who underwent gynecologic surgery for benign indications. Our findings could help surgeons minimize overprescribing and reduce medication diversion or misuse.SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020146120.PMID:36897135 | DOI:10.1097/AOG.0000000000005104
Source: Obstetrics and Gynecology - March 10, 2023 Category: OBGYN Authors: Kristen A Matteson Megan O Schimpf Peter C Jeppson Jennifer C Thompson Rajiv B Gala Sunil Balgobin Ankita Gupta Deslyn Hobson Cedric Olivera Ruchira Singh Amanda B White Ethan M Balk Kate V Meriwether Society of Gynecologic Surgeons Systematic Review Grou Source Type: research

the Effect of Pre-sacral Nerve Block on Post-operative Pain Following Laparoscopic Hysterectomy
Condition:   Gynecology Intervention:   Procedure: pre-sacral nerve block (bupivacaine injection into both uterosacral ligaments at the end of laparoscopic hysterectomy. Sponsor:   Ain Shams University Recruiting
Source: ClinicalTrials.gov - March 7, 2023 Category: Research Source Type: clinical trials